Tracking Cathie Wood: Added over 160,000 shares of gene-editing leader Intellia, reduced Roblox holdings to adjust allocation

U.S. stocks showed divergent trends on Monday. The S&P 500 closed down 0.28% at 7,652.86 points. Led by tech stocks, the Nasdaq fell 0.76% to 25,980.19 points, while the Dow Jones Industrial Average bucked the trend to rise 0.26% to 53,417.16 points, indicating some capital rotation and cautious market sentiment.

Amid this market environment, Cathie Wood significantly increased her positions in innovative pharmaceutical companies NTLA and FRNM on the day, while reducing her stake in metaverse platform RBLX.

Symbols

Buy Direction: Dual-line layout in precision medicine, continuing to bet on the gene revolution

$Intellia Therapeutics (NTLA.US)$ ARK increased its holding by 169,357 shares, marking the largest single purchase of the day. Intellia focuses on in vivo CRISPR gene-editing therapies, with its core pipeline holding significant first-mover advantages in multiple genetic disease areas. This likely aligns with ARK's high regard for foundational technology platforms in precision medicine. This substantial increase may reflect ARK's positive assessment of its clinical progress or recent news, suggesting considerable room for long-term valuation reshaping.

$Freenome (FRNM.US)$ Increased holdings by 12,938 shares. Freenome is dedicated to achieving early cancer screening through multi-omics blood testing technology, representing a highly disruptive innovator in the liquid biopsy sector. ARK's continued positioning in this stock may indicate optimism about the vast penetration potential of the early cancer detection market and the potential competitive moat built by its platform technology.

Sell Direction: Moderate adjustment of non-core holdings, liquidity rebalancing

$Roblox (RBLX.US)$ Reduced holdings by 26,199 shares. As a metaverse and user-generated content platform, Roblox possesses long-term conceptual appeal. However, amid current pressure on the broader tech sector, ARK's move may be a routine rebalancing of positions, or possibly a reallocation of capital to create space for higher-conviction targets such as those in precision medicine.

$Brera Holdings (SLMT.US)$ Reduced holdings by 10,661 shares. Brera Holdings is a relatively small-cap, non-core holding. The limited scale of this reduction suggests it is likely driven by portfolio optimization considerations, with minimal expected impact on the overall allocation strategy.

Futubull [Opportunity Page] has launched tracking for celebrity portfolio opportunities! Choose from multiple celebrity holdings, follow big investors' layouts with one click, precisely lock in high-quality targets, and invest with greater confidence!

47K Views